SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Provectus Pharmaceuticals Inc.
An SI Board Since April 2006
Posts SubjectMarks Bans Symbol
13111 103 0 PVCT
Emcee:  Jack Russell Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
13011Efficacy of intralesional injection with PV-10 in combination with co-inhibitoryboomertree2-11/6/2014
13010November 06, 2014 06:00 AM Eastern Standard Time KNOXVILLE, Tenn.--( BUSINESHoward Williams-11/6/2014
13009Wide-ranging PV-10 article in Medscape today http://www.medscape.com/viewarticlHoward Williams210/31/2014
13008Forbes article... To me this is big news. Not so much the content but who publisJack Russell-10/30/2014
13007SEC Insider-Trading Probe Centers On CMS. The Wall Street Journal (10/29, A1, boomertree2-10/29/2014
13006Could it be the FDA panders to big pharma? doing what they want including stalliJack Russell-10/28/2014
13005Those articles appear to be contrary to what the FDA has told PVCT. A bit baffliKhris Smith-10/27/2014
13004Analysis: Most Cancer Medications Approved With No Proof That They Extend Life. boomertree2-10/27/2014
13003Assume most of you have read or will read Alan Ross' latest post about how fLittlebits-10/21/2014
13002Howard good point. Yet we haven't seen a PR officially announcing it. I beMark Buczynski-10/17/2014
13001[Poll]FortStCowboy-10/10/2014
13000I missed these words in my original posting of today's news. IMO these are Howard Williams-10/3/2014
12999Provectus News Cutaneous, Locoregional Melanomas Show High, Rapid Responses toHoward Williams-10/3/2014
12998Immunotherapy Given Breakthrough Status In Melanoma. In continuing coverage, boomertree2-10/3/2014
12997Provectus Biopharmaceuticals' PV-10 Clinical Data on Melanoma Now Available Howard Williams-9/24/2014
12996Merck Faces Lawsuit Over Melanoma Immunotherapy Patent. The Wall Street Journboomertree2-9/8/2014
12995FDA Approves 27 New Medicines So Far This Year, Same Number As All Of 2013. Thboomertree2-9/8/2014
12994FDA Approves New Immunotherapy For Melanoma. There was wide coverage of the newboomertree2-9/5/2014
12993Sinopharm Starts Talks With Provectus Over Anticancer Thursday August 28, 2014 Howard Williams-8/28/2014
12992PVCT a breakout buy? thestreet.comHoward Williams-8/22/2014
129918k china MOU with China's largest pharmaceutical co, Sinopharm-ChinaMammon18/18/2014
12990Provectus Biopharmaceuticals Inc. to Commence Series of Quarterly Conference CalHoward Williams-8/6/2014
12989All old news...guess that is why it only took 2 days to review? Or maybe these kNTTG-8/1/2014
12988Excellent peer-reviewed PV-10 overview article by Dr. Merrick Ross *************Howard Williams-7/31/2014
12987The article below is a cut and paste copy of the linked article. I found it strHoward Williams27/18/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News